Responses
BASL abstracts
Viral hepatitis
P66 SVR with telaprevir, peginterferon alfa-2A and ribavirin in HCV patients with well-characterised prior null response, partial response, viral breakthrough or relapse after peginterferon+ ribavirin
Compose a Response to This Article
Other responses
No responses have been published for this article.